{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:33Z","timestamp":1786982193725,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kasr El-Aini Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The kidney represents an important target of systemic inflammation. Its involvement in monogenic and multifactorial autoinflammatory diseases (AIDs) vary from peculiar and relatively frequent manifestations to some rare but severe features that may end up requiring transplantation. The pathogenetic background is also very heterogeneous ranging from amyloidosis to non-amyloid related damage rooted in inflammasome activation. Kidney involvement in monogenic and polygenic AIDs may present as renal amyloidosis, IgA nephropathy, and more rarely as various forms of glomerulonephritis (GN), namely segmental glomerulosclerosis, collapsing glomerulopathy, fibrillar, or membranoproliferative GN. Vascular disorders such as thrombosis or renal aneurysms and pseudoaneurysms may be encountered in patients with Behcet\u2019s disease. Patients with AIDs should be routinely assessed for renal involvement. Screening with urinalysis, serum creatinine, 24-h urinary protein, microhematuria, and imaging studies should be carried out for early diagnosis. Awareness of drug-induced nephrotoxicity, drug-drug interactions as well as addressing the issue of proper renal adjustment of drug doses deserve a special mention and should always be considered when dealing with patients affected by AIDs. Finally, we will explore the role of IL-1 inhibitors in AIDs patients with renal involvement. Targeting IL-1 may indeed have the potential to successfully manage kidney disease and improve long-term prognosis of AIDs patients.<\/jats:p>","DOI":"10.1007\/s12026-023-09375-3","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T17:02:38Z","timestamp":1680109358000},"page":"578-587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Autoinflammatory diseases and the kidney"],"prefix":"10.1007","volume":"71","author":[{"given":"Mohamed Tharwat","family":"Hegazy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Fayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Nuzzolese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Sota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6529-0334","authenticated-orcid":false,"given":"Gaafar","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"issue":"5","key":"9375_CR1","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jaci.2020.08.017","volume":"146","author":"PA Nigrovic","year":"2020","unstructured":"Nigrovic PA, Lee PY, Hoffman HM. Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach. J Allergy Clin Immunol. 2020;146(5):925\u201337.","journal-title":"J Allergy Clin Immunol."},{"issue":"Suppl 110(1)","key":"9375_CR2","first-page":"3","volume":"36","author":"OM Lucherini","year":"2018","unstructured":"Lucherini OM, et al. Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases. Clin Exp Rheumatol. 2018;36(Suppl 110(1)):3\u20139.","journal-title":"Clin Exp Rheumatol."},{"issue":"3","key":"9375_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00247-019-04536-9","volume":"50","author":"M Navallas","year":"2020","unstructured":"Navallas M, et al. Autoinflammatory diseases in childhood, part 1: monogenic syndromes. Pediatr Radiol. 2020;50(3):415\u201330.","journal-title":"Pediatr Radiol."},{"key":"9375_CR4","doi-asserted-by":"publisher","first-page":"3293145","DOI":"10.1155\/2019\/3293145","volume":"2019","author":"C Gaggiano","year":"2019","unstructured":"Gaggiano C, et al. Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases. Mediators Inflamm. 2019;2019:3293145.","journal-title":"Mediators Inflamm."},{"issue":"6","key":"9375_CR5","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1681\/ASN.2010080798","volume":"22","author":"HJ Anders","year":"2011","unstructured":"Anders HJ, Muruve DA. The inflammasomes in kidney disease. J Am Soc Nephrol. 2011;22(6):1007\u201318.","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"9375_CR6","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/art.24735","volume":"61","author":"L Obici","year":"2009","unstructured":"Obici L, et al. Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview. Arthritis Rheum. 2009;61(10):1435\u201340.","journal-title":"Arthritis Rheum."},{"issue":"23","key":"9375_CR7","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann HJ, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356(23):2361\u201371.","journal-title":"N Engl J Med."},{"issue":"10038","key":"9375_CR8","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"AD Wechalekar","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016;387(10038):2641\u201354.","journal-title":"Lancet."},{"issue":"1","key":"9375_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/ndt\/gft332","volume":"29","author":"G Lorenz","year":"2013","unstructured":"Lorenz G, Darisipudi MN, Anders H-J. Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis. Nephrol Dial Transplant. 2013;29(1):41\u20138.","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"9375_CR10","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/ki.1994.117","volume":"45","author":"BJ Pereira","year":"1994","unstructured":"Pereira BJ, et al. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int. 1994;45(3):890\u20136.","journal-title":"Kidney Int."},{"issue":"2","key":"9375_CR11","doi-asserted-by":"publisher","first-page":"882","DOI":"10.4049\/jimmunol.154.2.882","volume":"154","author":"B Descamps-Latscha","year":"1995","unstructured":"Descamps-Latscha B, et al. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol. 1995;154(2):882\u201392.","journal-title":"J Immunol."},{"issue":"1","key":"9375_CR12","first-page":"141","volume":"151","author":"GH Tesch","year":"1997","unstructured":"Tesch GH, et al. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. Am J Pathol. 1997;151(1):141\u201350.","journal-title":"Am J Pathol."},{"issue":"3","key":"9375_CR13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0002-9440(10)65330-8","volume":"154","author":"XQ Yu","year":"1999","unstructured":"Yu XQ, et al. IL-1 Up-Regulates Osteopontin Expression in Experimental Crescentic Glomerulonephritis in the Rat. Am J Clin Pathol. 1999;154(3):833\u201341.","journal-title":"Am J Clin Pathol."},{"issue":"3","key":"9375_CR14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1681\/ASN.2010080892","volume":"23","author":"A Schreiber","year":"2012","unstructured":"Schreiber A, et al. Neutrophil serine proteases promote IL-1\u03b2 generation and injury in necrotizing crescentic glomerulonephritis. J Am Soc Nephrol. 2012;23(3):470\u201382.","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"9375_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/1470320314551564","volume":"16","author":"M Alique","year":"2015","unstructured":"Alique M, et al. Angiotensin II, via angiotensin receptor type 1\/nuclear factor-\u03baB activation, causes a synergistic effect on interleukin-1-\u03b2-induced inflammatory responses in cultured mesangial cells. J Renin Angiotensin Aldosterone Syst. 2015;16(1):23\u201332.","journal-title":"J Renin Angiotensin Aldosterone Syst."},{"issue":"13","key":"9375_CR16","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1089\/ars.2012.4666","volume":"18","author":"JM Abais","year":"2013","unstructured":"Abais JM, et al. NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia. Antioxid Redox Signal. 2013;18(13):1537\u201348.","journal-title":"Antioxid Redox Signal."},{"issue":"8","key":"9375_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00011-020-01354-w","volume":"69","author":"W Xiong","year":"2020","unstructured":"Xiong W, Meng X-F, Zhang C. Inflammasome activation in podocytes: a new mechanism of glomerular diseases. Inflamm Res. 2020;69(8):731\u201343.","journal-title":"Inflamm Res."},{"issue":"4","key":"9375_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2215\/CJN.07420716","volume":"12","author":"JC Rodrigues","year":"2017","unstructured":"Rodrigues JC, Haas M, Reich HN. IgA Nephropathy. Clin J Am Soc Nephrol. 2017;12(4):677\u201386.","journal-title":"Clin J Am Soc Nephrol."},{"key":"9375_CR19","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","volume":"2","author":"KN Lai","year":"2016","unstructured":"Lai KN, et al. IgA nephropathy. Nat Rev Dis Primers. 2016;2:16001.","journal-title":"Nat Rev Dis Primers."},{"key":"9375_CR20","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s10067-021-06006-w","volume":"41","author":"AE Beshlawy","year":"2022","unstructured":"Beshlawy AE, et al. Genotype-phenotype associations in familial Mediterranean fever: a study of 500 Egyptian pediatric patients. Clin Rheumatol. 2022;41:1511\u201321. https:\/\/doi.org\/10.1007\/s10067-021-06006-w.","journal-title":"Clin Rheumatol."},{"issue":"1","key":"9375_CR21","doi-asserted-by":"publisher","first-page":"24667","DOI":"10.1038\/srep24667","volume":"6","author":"J Chun","year":"2016","unstructured":"Chun J, et al. NLRP3 Localizes to the Tubular Epithelium in Human Kidney and Correlates With Outcome in IgA Nephropathy. Sci Rep. 2016;6(1):24667.","journal-title":"Sci Rep."},{"key":"9375_CR22","doi-asserted-by":"publisher","first-page":"41123","DOI":"10.1038\/srep41123","volume":"7","author":"Y-L Tsai","year":"2017","unstructured":"Tsai Y-L, et al. NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy. Sci Rep. 2017;7:41123.","journal-title":"Sci Rep."},{"issue":"6","key":"9375_CR23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1159\/000525001","volume":"146","author":"R Ebbestad","year":"2022","unstructured":"Ebbestad R, Sanaei Nurmi M, Lundberg S. Long-Term Outcomes of Patients with IgA Nephropathy Categorized by the International IgAN Risk Prediction Tool and by the Degree of Hematuria at Diagnosis. Nephron. 2022;146(6):573\u201383.","journal-title":"Nephron."},{"key":"9375_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.molimm.2019.07.017","volume":"114","author":"A Tortajada","year":"2019","unstructured":"Tortajada A, et al. The role of complement in IgA nephropathy. Mol Immunol. 2019;114:123\u201332.","journal-title":"Mol Immunol."},{"issue":"Suppl 110(1)","key":"9375_CR25","first-page":"54","volume":"36","author":"R Scarpioni","year":"2018","unstructured":"Scarpioni R, Obici L. Renal involvement in autoinflammatory diseases and inflammasome-mediated chronic kidney damage. Clin Exp Rheumatol. 2018;36(Suppl 110(1)):54\u201360.","journal-title":"Clin Exp Rheumatol."},{"issue":"5","key":"9375_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000506289","volume":"144","author":"F Yaz\u0131l\u0131ta\u015f","year":"2020","unstructured":"Yaz\u0131l\u0131ta\u015f F, et al. Clinicopathological Assessment of Kidney Biopsies in Children with Familial Mediterranean Fever: A Single-Center Experience. Nephron. 2020;144(5):222\u20137.","journal-title":"Nephron."},{"issue":"24","key":"9375_CR27","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMra010200","volume":"345","author":"JPH Drenth","year":"2001","unstructured":"Drenth JPH, van der Meer JWM. Hereditary Periodic Fever. N Engl J Med. 2001;345(24):1748\u201357.","journal-title":"N Engl J Med."},{"issue":"4","key":"9375_CR28","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/ndt\/gfk098","volume":"21","author":"G Rudofsky Jr","year":"2006","unstructured":"Rudofsky G Jr, et al. A nephrotic patient with tumour necrosis factor receptor-associated periodic syndrome, IgA nephropathy and CNS involvement. Nephrol Dial Transplant. 2006;21(4):1109\u201312.","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"9375_CR29","first-page":"427","volume":"16","author":"Y Pirson","year":"2003","unstructured":"Pirson Y. From renal amyloid deposits to the identification of the culprit genes. J Nephrol. 2003;16(3):427\u201330.","journal-title":"J Nephrol."},{"issue":"6","key":"9375_CR30","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1002\/art.21901","volume":"54","author":"HJ Lachmann","year":"2006","unstructured":"Lachmann HJ, et al. AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two cases. Arthritis Rheum. 2006;54(6):2010\u20134.","journal-title":"Arthritis Rheum."},{"key":"9375_CR31","doi-asserted-by":"publisher","first-page":"759092","DOI":"10.3389\/fmed.2021.759092","volume":"8","author":"P Borgia","year":"2021","unstructured":"Borgia P, et al. Kidney Involvement in PSTPIP1 Associated Inflammatory Diseases (PAID): A Case Report and Review of the Literature. Front Med (Lausanne). 2021;8:759092.","journal-title":"Front Med (Lausanne)."},{"issue":"4","key":"9375_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10875-016-0271-8","volume":"36","author":"TJ Vece","year":"2016","unstructured":"Vece TJ, et al. Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease. J Clin Immunol. 2016;36(4):377\u201387.","journal-title":"J Clin Immunol."},{"issue":"8","key":"9375_CR33","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.ekir.2019.04.014","volume":"4","author":"S Boulisfane-El Khalifi","year":"2019","unstructured":"Boulisfane-El Khalifi S, et al. COPA Syndrome as a Cause of Lupus Nephritis. Kidney Int Rep. 2019;4(8):1187\u20139.","journal-title":"Kidney Int Rep."},{"issue":"2","key":"9375_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1053\/j.ajkd.2019.07.010","volume":"75","author":"Q Abid","year":"2020","unstructured":"Abid Q, et al. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI). Am J Kidney Dis. 2020;75(2):287\u201390.","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"9375_CR35","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1053\/j.ajkd.2021.02.330","volume":"78","author":"P Fenaroli","year":"2021","unstructured":"Fenaroli P, et al. Collapsing Glomerulopathy as a Complication of Type I Interferon-Mediated Glomerulopathy in a Patient With RNASEH2B-Related Aicardi-Gouti\u00e8res Syndrome. Am J Kidney Dis. 2021;78(5):750\u20134.","journal-title":"Am J Kidney Dis."},{"key":"9375_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/0-306-48382-3_97","volume":"528","author":"F Shahram","year":"2003","unstructured":"Shahram F, et al. Urine abnormalities in Beh\u00e7et's disease. Study of 4704 cases. Adv Exp Med Biol. 2003;528:477\u20138.","journal-title":"Adv Exp Med Biol."},{"issue":"3","key":"9375_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.semarthrit.2007.11.001","volume":"38","author":"T Akpolat","year":"2008","unstructured":"Akpolat T, et al. Renal Beh\u00e7et's Disease: An Update. Semin Arthritis Rheum. 2008;38(3):241\u20138.","journal-title":"Semin Arthritis Rheum."},{"issue":"8","key":"9375_CR38","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/1756-185X.12529","volume":"18","author":"W Zheng","year":"2015","unstructured":"Zheng W, et al. Renal involvement in Chinese patients with Behcet's disease: a report of 16 cases. Int J Rheum Dis. 2015;18(8):892\u20137.","journal-title":"Int J Rheum Dis."},{"issue":"3","key":"9375_CR39","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11255-012-0268-z","volume":"45","author":"K Kosemehmetoglu","year":"2013","unstructured":"Kosemehmetoglu K, Baydar DE. Renal amyloidosis in Beh\u00e7et's disease: clinicopathologic features of 8 cases. Int Urol Nephrol. 2013;45(3):785\u201394.","journal-title":"Int Urol Nephrol."},{"issue":"6","key":"9375_CR40","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s10067-006-0435-7","volume":"26","author":"U Utku","year":"2007","unstructured":"Utku U, et al. SAA1 alpha\/alpha alleles in Beh\u00e7et's disease related amyloidosis. Clin Rheumatol. 2007;26(6):927\u20139.","journal-title":"Clin Rheumatol."},{"issue":"7","key":"9375_CR41","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s00296-011-2051-3","volume":"32","author":"M Altay","year":"2012","unstructured":"Altay M, et al. Behcet's disease and IgA nephropathy. Rheumatol Int. 2012;32(7):2227\u20139.","journal-title":"Rheumatol Int."},{"issue":"5","key":"9375_CR42","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3109\/0886022X.2012.664507","volume":"34","author":"HJ Kim","year":"2012","unstructured":"Kim HJ, et al. Fibrillary glomerulonephritis associated with Beh\u00e7et's syndrome. Ren Fail. 2012;34(5):637\u20139.","journal-title":"Ren Fail."},{"issue":"1","key":"9375_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1\u201311.","journal-title":"Arthritis Rheum."},{"issue":"28","key":"9375_CR44","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1097\/MD.0000000000000263","volume":"93","author":"X Wu","year":"2014","unstructured":"Wu X, et al. Beh\u00e7et's disease complicated with thrombosis: a report of 93 Chinese cases. Medicine. 2014;93(28):e263.","journal-title":"Medicine."},{"key":"9375_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.12659\/PJR.895446","volume":"81","author":"D Ozel","year":"2016","unstructured":"Ozel D, et al. Evalution of Renal Involvement in Patients with Beh\u00e7et Disease: Need to be Aware About Potential Hypertension in Long Term Follow Up? Pol J Radiol. 2016;81:5\u20139.","journal-title":"Pol J Radiol."},{"issue":"2","key":"9375_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/1538574417689982","volume":"51","author":"O Ali","year":"2017","unstructured":"Ali O, et al. Multiple Aneurysms and a Transplanted Kidney in Beh\u00e7et Disease. Vasc Endovasc Surg. 2017;51(2):108\u201310.","journal-title":"Vasc Endovasc Surg."},{"issue":"2","key":"9375_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.krcp.2015.09.001","volume":"35","author":"S Park","year":"2016","unstructured":"Park S, et al. Successfully treated isolated renal artery pseudoaneurysm in a patient with Beh\u00e7et's disease. Kidney Res Clin Pract. 2016;35(2):123\u20136.","journal-title":"Kidney Res Clin Pract."},{"issue":"7","key":"9375_CR48","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1468-3083.2009.03488.x","volume":"24","author":"M Kavala","year":"2010","unstructured":"Kavala M, et al. Microalbuminuria as an early marker of renal involvement in Behcet's disease: it is associated with neurological involvement and duration of the disease. J Eur Acad Dermatol Venereol. 2010;24(7):840\u20133.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"1","key":"9375_CR49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12882-017-0451-7","volume":"18","author":"T Higashihara","year":"2017","unstructured":"Higashihara T, et al. A novel case of renal pathergy reaction in a Beh\u00e7et\u2019s disease patient complicated by IgA vasculitis. BMC Nephrol. 2017;18(1):40.","journal-title":"BMC Nephrol."},{"issue":"6","key":"9375_CR50","doi-asserted-by":"publisher","first-page":"497","DOI":"10.5414\/CN107135","volume":"78","author":"Y Iwafuchi","year":"2012","unstructured":"Iwafuchi Y, et al. Schnitzler syndrome complicated by membranous nephropathy. Clin Nephrol. 2012;78(6):497\u2013500.","journal-title":"Clin Nephrol."},{"issue":"1","key":"9375_CR51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/ajkd.2002.29918","volume":"39","author":"A O'Hare","year":"2002","unstructured":"O'Hare A, et al. Renal insufficiency with monoclonal gammopathy and urticarial vasculitis. Am J Kidney Dis. 2002;39(1):203\u20137.","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"9375_CR52","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/ckj\/sfx077","volume":"10","author":"C Basile","year":"2017","unstructured":"Basile C, et al. Kidney involvement in the Schnitzler syndrome, a rare disease. Clin Kidney J. 2017;10(6):723\u20137.","journal-title":"Clin Kidney J."},{"issue":"4","key":"9375_CR53","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10067-009-1331-8","volume":"29","author":"T Babacan","year":"2010","unstructured":"Babacan T, et al. Successful treatment of refractory adult Still's disease and membranous glomerulonephritis with infliximab. Clin Rheumatol. 2010;29(4):423\u20136.","journal-title":"Clin Rheumatol."},{"issue":"5","key":"9375_CR54","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1053\/j.ajkd.2003.11.025","volume":"43","author":"S Kumar","year":"2004","unstructured":"Kumar S, Sheaff M, Yaqoob M. Collapsing glomerulopathy in adult still's disease. Am J Kidney Dis. 2004;43(5):e4\u201310.","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"9375_CR55","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/rheumatology\/keh172","volume":"43","author":"AN Bennett","year":"2004","unstructured":"Bennett AN, et al. Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology. 2004;43(6):795\u20139.","journal-title":"Rheumatology."},{"issue":"7","key":"9375_CR56","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/ndt\/12.7.1471","volume":"12","author":"J Portol\u00e9s","year":"1997","unstructured":"Portol\u00e9s J, et al. Thrombotic thrombocytopenic purpura and acute renal failure in adult Still's disease. Nephrol Dial Transplant. 1997;12(7):1471\u20133.","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"9375_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/01.SMJ.0000047763.56451.F0","volume":"96","author":"MG Perez","year":"2003","unstructured":"Perez MG, Rodwig FR Jr. Chronic relapsing thrombotic thrombocytopenic purpura in adult onset Still's disease. South Med J. 2003;96(1):46\u20139.","journal-title":"South Med J."},{"key":"9375_CR58","doi-asserted-by":"crossref","unstructured":"Kang JH. IgA nephropathy in adult-onset Still's disease after tocilizumab treatment: a case report. Int Urol Nephrol. 2021;54(5):1167-8","DOI":"10.1007\/s11255-021-02956-x"},{"issue":"6","key":"9375_CR59","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s10157-011-0546-6","volume":"15","author":"J Sayegh","year":"2011","unstructured":"Sayegh J, et al. Necrotizing crescentic immunoglobulin A glomerulonephritis in adult-onset Still's disease. Clin Exp Nephrol. 2011;15(6):978\u20139.","journal-title":"Clin Exp Nephrol."},{"key":"9375_CR60","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00105-018-4250-2","volume":"69","author":"FF Gellrich","year":"2019","unstructured":"Gellrich FF, G\u00fcnther C. Schnitzler syndrome. Hautarzt. 2019;69:761\u201372.","journal-title":"Hautarzt."},{"issue":"1","key":"9375_CR61","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.semarthrit.2019.08.005","volume":"50","author":"M Delplanque","year":"2020","unstructured":"Delplanque M, et al. AA amyloidosis secondary to adult onset Still's disease: About 19 cases. Semin Arthritis Rheum. 2020;50(1):156\u201365.","journal-title":"Semin Arthritis Rheum."},{"issue":"1","key":"9375_CR62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00467-012-2295-5","volume":"28","author":"K Sugimoto","year":"2013","unstructured":"Sugimoto K, et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome and IgA nephropathy. Pediatr Nephrol. 2013;28(1):151\u20134.","journal-title":"Pediatr Nephrol."},{"key":"9375_CR63","doi-asserted-by":"publisher","unstructured":"Roccatello D, et al. Renal involvement as a unique manifestation of hemophagocytic syndrome. In: The kidney in auto-immune and auto-inflammatory processes: Definitions, mechanisms, and biomarkers. Frontiers Media SA; 2022;9:796121.\u00a0https:\/\/doi.org\/10.3389\/fmed.2022.796121.","DOI":"10.3389\/fmed.2022.796121"},{"issue":"4","key":"9375_CR64","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/art.37827","volume":"65","author":"T Lane","year":"2013","unstructured":"Lane T, et al. Brief Report: AA Amyloidosis Complicating the Hereditary Periodic Fever Syndromes. Arthritis Rheumatol. 2013;65(4):1116\u201321.","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"9375_CR65","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10067-014-2772-2","volume":"35","author":"ZB \u00d6z\u00e7akar","year":"2016","unstructured":"\u00d6z\u00e7akar ZB, et al. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis. Clin Rheumatol. 2016;35(2):441\u20136.","journal-title":"Clin Rheumatol."},{"issue":"Suppl 2","key":"9375_CR66","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1136\/annrheumdis-2016-eular.5917","volume":"75","author":"H Ozdogan","year":"2016","unstructured":"Ozdogan H, et al. AB0906\u00a0Anti-Interleukin-1 Therapy in Familial Mediterranean Fever Amyloidosis: A Single Center Experience. Ann Rheum Dis. 2016;75(Suppl 2):1212.","journal-title":"Ann Rheum Dis."},{"issue":"5","key":"9375_CR67","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00296-018-3993-5","volume":"38","author":"F Yaz\u0131l\u0131ta\u015f","year":"2018","unstructured":"Yaz\u0131l\u0131ta\u015f F, et al. Canakinumab treatment in children with familial Mediterranean fever: report from a single center. Rheumatol Int. 2018;38(5):879\u201385.","journal-title":"Rheumatol Int."},{"issue":"3","key":"9375_CR68","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1681\/ASN.2016040453","volume":"28","author":"KL Nowak","year":"2017","unstructured":"Nowak KL, et al. IL-1 Inhibition and Vascular Function in CKD. J Am Soc Nephrol. 2017;28(3):971\u201380.","journal-title":"J Am Soc Nephrol."},{"issue":"15","key":"9375_CR69","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa065213","volume":"356","author":"CM Larsen","year":"2007","unstructured":"Larsen CM, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007;356(15):1517\u201326.","journal-title":"N Engl J Med."},{"issue":"9888","key":"9375_CR70","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260\u201372.","journal-title":"Lancet."},{"issue":"3","key":"9375_CR71","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1681\/ASN.2010070760","volume":"22","author":"AM Hung","year":"2011","unstructured":"Hung AM, et al. IL-1\u03b2 receptor antagonist reduces inflammation in hemodialysis patients. J Am Soc Nephrol. 2011;22(3):437\u201342.","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"9375_CR72","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/ndt\/gfn646","volume":"24","author":"C Moser","year":"2009","unstructured":"Moser C, et al. Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation. Nephrol Dial Transplant. 2009;24(2):676\u20138.","journal-title":"Nephrol Dial Transplant."},{"key":"9375_CR73","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fphar.2017.00342","volume":"8","author":"CM Mulders-Manders","year":"2017","unstructured":"Mulders-Manders CM, et al. Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature. Front Pharmacol. 2017;8:342.","journal-title":"Front Pharmacol."},{"issue":"7","key":"9375_CR74","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.transproceed.2019.03.049","volume":"51","author":"DO Sendogan","year":"2019","unstructured":"Sendogan DO, et al. Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series. Transplant Proc. 2019;51(7):2292\u20134.","journal-title":"Transplant Proc."},{"issue":"6","key":"9375_CR75","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jbspin.2018.03.015","volume":"85","author":"C Loustau","year":"2018","unstructured":"Loustau C, et al. Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study. Joint Bone Spine. 2018;85(6):755\u201360.","journal-title":"Joint Bone Spine."}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-023-09375-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-023-09375-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-023-09375-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T04:04:56Z","timestamp":1691985896000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-023-09375-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["9375"],"URL":"https:\/\/doi.org\/10.1007\/s12026-023-09375-3","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"5 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}